Debut Biotechnology

Debut Biotechnology joined Merck and the lab on the scalable total synthesis of saxitoxin.

San Diego, California

Papers together
1
Years
2025
Co-authors
1
The record

Our paper with Debut Biotechnology

All partners →
  1. Scalable Total Synthesis of Saxitoxin and Related Natural Products

    Nature 2025 · doi:10.1038/s41586-025-09551-5 · In our publications

    • Merck & Co. Christopher K. Prier, Kai-Jiong Xiao
    • Debut Biotechnology Christopher K. Prier

Our co-authors at Debut Biotechnology

Christopher K. Prier

Some of these papers were shared with another partner: Merck & Co..

Work with us

Interested in collaborating with the Baran lab?

If your team has a problem that matters, a molecule no one can make, a reaction that will not scale, a reagent that should exist, we would love to hear about it.

Email Phil

or write to pbaran@scripps.edu